Table 4.

Proportion of men with a higher, stabilized, or lower PSA at M6

PSA M0–M6 progressionPlacebo, n (%)Sulphoraphane, n (%)
Increase (>20%)28 (71.8%)16 (44.4%)
Stabilization (>−10% and <20%)10 (25.6%)16 (44.4%)
Decrease (<−10%)1 (2.6%)4 (11.2%)

NOTE: P = 0.0163, χ2 test.